Human kallikrein gene delivery attenuates hypertension, cardiac hypertrophy, and renal injury in Dahl salt-sensitive rats

Human Gene Therapy

Volumn 9, Issue 1, 1998, Pages 21-31

  Chao, Julie ^a   Zhang, Jenny J ^a   Lin, Kuei Fu ^a   Lee, Chao ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC GMP; KALLIKREIN; KININ; MESSENGER RNA; SODIUM;

ADENOVIRUS; ADRENAL GLAND; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS; GENE TARGETING; HEART; HEART LEFT VENTRICLE MASS; HEART VENTRICLE HYPERTROPHY; HYPERTENSION; KIDNEY; KIDNEY INJURY; LIVER; LUNG; MALE; NONHUMAN; RAT; SIGNAL TRANSDUCTION; SODIUM URINE LEVEL; URINARY EXCRETION;

EID: 0031965113     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.1998.9.1-21     Document Type: Article

References (13)

1. ADER, J.L., POLLOCK, D.M., BUTTERFIELD, M.I., and ARENDSHORST, W.J. (1985). Abnormalities in kallikrein excretion in spontaneously hypertensive rats. Am J. Physiol. 258, F396-F403.
2. BERRY, T.D., HASSTEDT, S.J., HUNT, S.C., WU, L.L., SMITH, J.B., ASH, K.O., KUIDA, H., and WILLIAMS, R.R. (1989). A gene for high urinary kallikrein may protect against hypertension in Utah kindreds. Hypertension 13, 3-8.
3. BHOOLA, K.D., FIGUEROA, C.D., and WORTHY, K. (1992). Bioregulation of kinins: Kallikreins, kininogens, and kininases. Pharmacol. Rev. 44, 1-8.
4. BOUHNIK, J., RICHOUX, J.P., HUANG, H., SAVOIE, F., BAUSSANT, T., ALHENC-GELAS, F., and CORVOL, P. (1992). Hypertension in Dahl salt-sensitive rats: Biochemical and immunohistochemical studies. Clin. Sci. 83, 13-22.
5. CHAO, J., and CHAO, L. (1997). Kallikrein gene therapy: A new strategy for hypertensive diseases. Immunopharmacology 36, 229-236.
6. CHAO, J., JIN, L., CHEN, L.M., CHEN, V.C., and CHAO, L. (1996). Systemic and portal vein delivery of human kallikrein gene reduces blood pressure in hypertensive rats. Hum. Gene Ther. 7, 901-911.
7. CHAD, J., JIN, L., LIN, K.F., and CHAO, L. (1997). Adrenomedullin gene delivery reduces blood pressure in spontaneously hypertensive rats. Hypertens. Res. (in press).
8. CLEMENTS, J.A. (1989). The glandular kallikrein family of enzymes: Tissue-specific expression and hormonal regulation. Endocrine Rev. 10, 393-419.
9. FAVARO, S., BAGGIO, B., ANTONELLO, A., ZEN, A., CANNELLA, G., TODESCO, S., and BORSATTI, A. (1975). Renal kallikrein content of spontaneously hypertensive rats. Clin. Sci. Mol. Med. 49, 69-71.
10. GELLER, R.G., MARGOLIUS, H.S., PISANO, J J., and KEISER, H.R. (1975). Urinary kallikrein excretion in spontaneously hypertensive rats. Circ. Res. 36 (Suppl. 1), 103-106.
11. JOOSS, K., YANG, Y., and WILSON, J.M. (1996). Cyclophosphamide diminishes inflammation and prolongs transgene expression following delivery of adenoviral vectors to mouse liver and lung. Hum. Gene Ther. 7, 1555-1566.
12. KAPLAN, J.M., and SMITH, A.E. (1997). Transient immunosuppression with deoxyspergualin improves longevity of transgene expression and ability to readminister adenoviral vector to the mouse lung. Hum. Gene Ther. 8, 1095-1104.
13. LIN, K.F., CHAO, J., and CHAO, L. (1995). Human atrial natriuretic peptide gene delivery reduces blood pressure in hypertensive rats. Hypertension 26, 847-853.